What Is Acute Lymphocytic Leukemia?

This content has been reviewed and approved by

Hagop M. Kantarjian, MD
Chairman & Professor, Leukemia Department
MD Anderson Cancer Center
University of Texas
 

Leukemia is cancer of the blood cells, usually the white blood cells. Acute lymphocytic leukemia (ALL) occurs when bone marrow and the lymph system produce too many lymphocytes. A lymphocyte is a type of white blood cell that fights infection by making antibodies that attack harmful organisms.

About 5,430 people in the United States will be diagnosed with ALL in 2008, according to the American Cancer Society. Although ALL is the most common leukemia in children, approximately one-third of cases occur in adults.

A person with ALL has immature lymphocytes that cannot function properly. They crowd out other blood cells and may collect in blood, bone marrow, and lymph tissue. People with ALL have difficulty in fighting infection. They also have a low platelet count and may have bleeding problems. They also do not produce hemoglobin or red cells (that carry oxygen), so they may have anemia and feel tired.

The word "acute" means sudden or rapid in onset. Acute leukemia can occur in a short period of days or weeks. Chromosome (DNA) abnormalities (extra chromosomes and structural changes in the chromosome material) are present in the majority of patients with ALL.

This content was last modified on August 11, 2007 .
Latest Cancer News
ACOG Updates Cervical Cancer Screening Guidelines

November 20, 2009 — The American College of Obstetricians and Gynecologists (ACOG) has revised its cervical cancer screening recommendations: the organization now recommends that women begin screening at the age of 21 and receive screening at less frequent intervals. These recommendations will be published in the December 2009 issue of Obstetrics and Gynecology.

New Velcade®-melphalan Transplant Regimen for Multiple Myeloma

November 20, 2009 — Researchers from France have reported encouraging results with adding Velcade® (bortezomib) to high-dose melphalan followed by autologus stem cell infusion for initial treatment of patients with newly diagnosed multiple myeloma. The details of this Phase II study appeared in an early online publication in Blood on November 2, 2009.

Folic Acid May Be Beneficial in Patients with Recurrent Colorectal Adenoma Who Are Folate Deficient

November 20, 2009 — Researchers affiliated with the Health Professional Follow-Up Study and the Nurses’ Health Study have reported that folic acid supplementation in patients with recurrent colorectal adenoma was not protective or harmful in most patients. However, patients who were folate deficient had a significant 39% decrease in adenoma recurrence. The details of this study appeared in an early online publication on October 28, 2009 in the American Journal of Clinical Nutrition.

Select news items provided by Reuters Health